The significance of the expression of ERRα as a potential biomarker in breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 113, Issue 1-2, 2009, Pages 127-133

  Jarzabek, Katarzyna ^a   Koda, Mariusz ^a   Kozlowski, Leszek ^a   Sulkowski, Stanislaw ^a   Kottler, Marie Laure ^b   Wolczynski, Slawomir ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Department Genetique et Reproduction CHU Caen ^*  (France)

Author keywords

Aromatase; Breast cancer; c myc; Estrogen receptor ; Estrogen related receptor

Indexed keywords

AROMATASE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR ALPHA; KI 67 ANTIGEN; MYC PROTEIN; ERRALPHA ESTROGEN RELATED RECEPTOR; ERRALPHA ESTROGEN-RELATED RECEPTOR; ESTROGEN RECEPTOR; MESSENGER RNA; TUMOR MARKER;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BREAST TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

AROMATASE; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ESTROGEN; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 59849121296     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.12.005     Document Type: Article

References (51)

1. DeNardo D.G., Cuba V.L., Kim H., Wu K., Lee A.V., and Brown P.H. Estrogen receptor DNA binding is not required for estrogen-induced breast cell growth. Mol. Cell. Endocrinol. 277 (2007) 13-25
2. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., and Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74 (2000) 311-317
3. Ray P., Ghosh S.K., Zhang D.H., and Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett. 409 (1997) 79-85
4. Safe S. Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam. Horm. 62 (2001) 231-252
5. Giguère V., Yang N., Segui P., and Evans R.M. Identification of a new class of steroid hormone receptors. Nature 331 (1988) 91-94
6. Eudy J.D., Yao S., Weston M.D., Ma-Edmonds M., Talmadge C.B., Cheng J.J., Kimberling W.J., and Sumegi J. Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41. Genomics 50 (1998) 382-384
7. Lin C.Y., Vega V.B., Thomsen J.S., Zhang T., Kong S.L., Xie M., Chiu K.P., Lipovich L., Barnett D.H., Stossi F., Yeo A., George J., Kuznetsov V.A., Lee Y.K., Charn T.H., Palanisamy N., Miller L.D., Cheung E., Katzenellenbogen B.S., Ruan Y., Bourque G., Wei C.L., and Liu E.T. Whole-genome cartography of estrogen receptor alpha binding sites. PLOS Genet. 3 (2007) e87
8. Vanacker J.M., Pettersson K., Gustafsson J.A., and Laudet V. Transcriptional targets shared by estrogen receptor-related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ER beta. EMBO J. 18 (1999) 4270-4279
9. Yang N., Shigeta H., Shi H., and Teng C.T. Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter. J. Biol. Chem. 271 (1996) 5795-5804
10. Teyssier C., Bianco S., Lanvin O., and Vanacker J.M. The orphan receptor ERRalpha interferes with steroid signaling. Nucleic Acids Res. 36 (2008) 5350-5361
11. Xie W., Hong H., Yang N.N., Lin R.J., Simon C.M., Stallcup M.R., and Evans R.M. Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. Mol. Endocrinol. 13 (1999) 2151-2162
12. Chen S., Zhou D., Yang C., and Sherman M. Molecular basis for the constitutive activity of estrogen-related receptor alpha-1. J. Biol. Chem. 276 (2001) 28465-28470
13. Huss J.M., Kopp R.P., and Kelly D.P. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J. Biol. Chem. 277 (2002) 40265-40274
14. Kallen J., Schlaeppi J.M., Bitsch F., Filipuzzi I., Schilb A., Riou V., Graham A., Strauss A., Geiser M., and Fournier B. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha. J. Biol. Chem. 279 (2004) 49330-49337
15. Greschik H., Wurtz J.M., Sanglier S., Bourguet W., van Dorsselaer A., Moras D., and Renaud J.P. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol. Cell 9 (2002) 303-313
16. Kallen J., Lattmann R., Beerli R., Blechschmidt A., Blommers M.J., Geiser M., Ottl J., Schlaeppi J.M., Strauss A., and Fournier B. Crystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse agonist reveals its novel molecular mechanism. J. Biol. Chem. 282 (2007) 23231-23239
17. Wang L., Zuercher W.J., Consler T.G., Lambert M.H., Miller A.B., Orband-Miller L.A., McKee D.D., Willson T.M., and Nolte R.T. X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation. J. Biol. Chem. 281 (2006) 37773-37781
18. Sanyal S., Matthews J., Bouton D., Kim H.J., Choi H.S., Treuter E., and Gustafsson J.A. Deoxyribonucleic acid response element-dependent regulation of transcription by orphan nuclear receptor estrogen receptor-related receptor gamma. Mol. Endocrinol. 18 (2004) 312-325
19. Stein R.A., and McDonnell D.P. Estrogen-related receptor alpha as a therapeutic target in cancer. Endocr. Relat. Cancer 13 (2006) 25-32
20. Yang C., Zhou D., and Chen S. Modulation of aromatase expression in the breast tissue by ERR alpha-1 orphan receptor. Cancer Res. 58 (1998) 5695-5700
21. Seely J., Amigh K.S., Suzuki T., Mayhew B., Sasano H., Giguere V., Laganière J., Carr B.R., and Rainey W.E. Transcriptional regulation of dehydroepiandrosterone sulfotransferase (SULT2A1) by estrogen-related receptor alpha. Endocrinology 146 (2005) 3605-3613
22. O'Neill J.S., Elton R.A., and Miller W.R. Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. Br. Med. J. (Clin. Res. Ed.) 296 (1988) 741-743
23. Bulun S.E., Price T.M., Aitken J., Mahendroo M.S., and Simpson E.R. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J. Clin. Endocrinol. Metab. 77 (1993) 1622-1628
24. Liao D.J., and Dickson R.B. c-Myc in breast cancer. Endocr. Relat. Cancer 7 (2000) 143-164
25. Robanus-Maandag E.C., Bosch C.A., Kristel P.M., Hart A.A., Faneyte I.F., Nederlof P.M., Peterse J.L., and van de Vijver M.J. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas. J. Pathol. 201 (2003) 75-82
26. Deming S.L., Nass S.J., Dickson R.B., and Trock B.J. C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br. J. Cancer 83 (2000) 1688-1695
27. Ruiz C., Seibt S., Al Kuraya K., Siraj A.K., Mirlacher M., Schraml P., Maurer R., Spichtin H., Torhorst J., Popovska S., Simon R., and Sauter G. Tissue microarrays for comparing molecular features with proliferation activity in breast cancer. Int. J. Cancer 118 (2006) 2190-2194
28. Berns E.M., Klijn J.G., Smid M., van Staveren I.L., Look M.P., van Putten W.L., and Foekens J.A. TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients. Genes Chromosomes Cancer 16 (1996) 170-179
29. Al-Kuraya K., Schraml P., Torhorst J., Tapia C., Zaharieva B., Novotny H., Spichtin H., Maurer R., Mirlacher M., Köchli O., Zuber M., Dieterich H., Mross F., Wilber K., Simon R., and Sauter G. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res. 64 (2004) 8534-8540
30. McNeil C.M., Sergio C.M., Anderson L.R., Inman C.K., Eggleton S.A., Murphy N.C., Millar E.K., Crea P., Kench J.G., Alles M.C., Gardiner-Garden M., Ormandy C.J., Butt A.J., Henshall S.M., Musgrove E.A., and Sutherland R.L. c-Myc overexpression and endocrine resistance in breast cancer. J. Steroid Biochem. Mol. Biol. 102 (2006) 147-155
31. Tavassoli F.A., and Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs (2003), IARC Press, Lyon pp. 9-59
32. Bloom H.J.G., and Richardson W.W. Histological grading and prognosis in breast cancer. Br. J. Cancer 11 (1957) 359-377
33. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
34. Bouraïma H., Hanoux V., Mittre H., Feral C., Benhaïm A., and Leymarie P. Quantification of cytochrome P450 aromatase transcripts before and during luteal phase in rabbit. Mol. Cell. Endocrinol. 196 (2002) 43-51
35. Jarzabek K., Koda M., Kozlowski L., Mittre H., Sulkowski S., Kottler M.L., and Wolczynski S. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors. Eur. J. Cancer 41 (2005) 2924-2934
36. Sladek R., Bader J.A., and Giguère V. The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol. Cell. Biol. 17 (1997) 5400-5409
37. Giguère V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr. Rev. 29 (2008) 677-696
38. Ao A., Wang H., Kamarajugadda S., and Lu J. Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 7821-7826
39. Giguère V. To ERR in the estrogen pathway. Trends Endocrinol. Metab. 13 (2002) 220-225
40. Suzuki T., Miki Y., Moriya T., Shimada N., Ishida T., Hirakawa H., Ohuchi N., and Sasano H. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. Cancer Res. 64 (2004) 4670-4676
41. Lu D., Kiriyama Y., Lee K.Y., and Giguère V. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. Cancer Res. 61 (2001) 6755-6761
42. Kinoshita Y., and Chen S. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Cancer Res. 63 (2003) 3546-3555
43. Zhang Z., and Teng C.T. Estrogen receptor-related receptor alpha 1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. J. Biol. Chem. 275 (2000) 20837-20846
44. Vanacker J.M., Bonnelye E., Chopin-Delannoy S., Delmarre C., Cavaillès V., and Laudet V. Transcriptional activities of the orphan nuclear receptor ERR alpha (estrogen receptor-related receptor-alpha). Mol. Endocrinol. 13 (1999) 764-773
45. Ariazi E.A., Clark G.M., and Mertz J.E. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res. 62 (2002) 6510-6518
46. Watanabe A., Kinoshita Y., Hosokawa K., Mori T., Yamaguchi T., and Honjo H. Function of estrogen-related receptor alpha in human endometrial cancer. J. Clin. Endocrinol. Metab. 91 (2006) 1573-1577
47. Simpson E.R., Clyne C., Speed C., Rubin G., and Bulun S. Tissue-specific estrogen biosynthesis and metabolism. Ann. NY Acad. Sci. 949 (2001) 58-67
48. Miki Y., Suzuki T., Tazawa C., Yamaguchi Y., Kitada K., Honma S., Moriya T., Hirakawa H., Evans D.B., Hayashi S., Ohuchi N., and Sasano H. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells. Cancer Res. 67 (2007) 3945-3954
49. Apak T.I., and Duffel M.W. Interactions of the stereoisomers of alpha-hydroxytamoxifen with human hydroxysteroid sulfotransferase SULT2A1 and rat hydroxysteroid sulfotransferase Sta. Drug Metab. Dispos. 32 (2004) 1501-1508
50. Sun P., Sehouli J., Denkert C., Mustea A., Könsgen D., Koch I., Wei L., and Lichtenegger W. Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells. J. Mol. Med. 83 (2005) 457-467
51. Lanvin O., Bianco S., Kersual N., Chalbos D., and Vanacker J.M. Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790. J. Biol. Chem. 282 (2007) 28328-28334